iBio (IBIO) Retained Earnings (2016 - 2025)
Historic Retained Earnings for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$346.9 million.
- iBio's Retained Earnings fell 767.75% to -$346.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$346.9 million, marking a year-over-year decrease of 767.75%. This contributed to the annual value of -$332.2 million for FY2025, which is 585.54% down from last year.
- Per iBio's latest filing, its Retained Earnings stood at -$346.9 million for Q4 2025, which was down 767.75% from -$337.9 million recorded in Q3 2025.
- In the past 5 years, iBio's Retained Earnings ranged from a high of -$173.6 million in Q2 2021 and a low of -$346.9 million during Q4 2025
- Its 5-year average for Retained Earnings is -$272.3 million, with a median of -$291.8 million in 2023.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 4171.35% in 2022, then tumbled by 585.54% in 2025.
- Over the past 5 years, iBio's Retained Earnings (Quarter) stood at -$194.5 million in 2021, then tumbled by 41.71% to -$275.6 million in 2022, then fell by 9.9% to -$302.9 million in 2023, then decreased by 6.37% to -$322.2 million in 2024, then dropped by 7.68% to -$346.9 million in 2025.
- Its last three reported values are -$346.9 million in Q4 2025, -$337.9 million for Q3 2025, and -$332.2 million during Q2 2025.